MacroGenics
MGNX
#9241
Rank
C$0.13 B
Marketcap
C$2.20
Share price
-0.62%
Change (1 day)
-52.69%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$0.27 Billion

According to MacroGenics's latest financial reports the company's total liabilities are C$0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$0.20 B8.04%
2023-12-31C$0.19 B2.93%
2022-12-31C$0.18 B54.16%
2021-12-31C$0.12 B15.35%
2020-12-31C$0.10 B-1.2%
2019-12-31C$0.10 B-12.05%
2018-12-31C$0.12 B29.55%
2017-12-31C$93.84 M64.27%
2016-12-31C$57.12 M-10.34%
2015-12-31C$63.71 M4.38%
2014-12-31C$61.04 M22.35%
2013-12-31C$49.89 M-19.06%
2012-12-31C$61.63 M-24.41%
2011-12-31C$81.54 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Xencor
XNCR
C$0.33 B 19.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$158.08 B 56,650.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$106.14 B 38,002.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$50.68 B 18,096.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$110.08 B 39,417.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$124.52 B 44,601.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$107.02 B 38,321.79%๐Ÿ‡บ๐Ÿ‡ธ USA